Thalia Therapeutics says patent granted for Miristen in China
Reuters says Thalia Therapeutics PLC has received a new patent grant for Miristen in China. Phase 1 results for Miristen are expected in H1 2027.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Thalia Therapeutics Says New Patent Granted For Miristen In China
Thalia Therapeutics PLC LSE:THAT